These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 17301610

  • 1. Evolving global risk assessment of ocular hypertension to glaucoma.
    Fechtner RD, Khouri AS.
    Curr Opin Ophthalmol; 2007 Mar; 18(2):104-9. PubMed ID: 17301610
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Glaucoma risk factor assessment and prevention: lessons from coronary heart disease.
    Girkin CA, Kannel WB, Friedman DS, Weinreb RN.
    Am J Ophthalmol; 2004 Sep; 138(3 Suppl):S11-8. PubMed ID: 15364048
    [Abstract] [Full Text] [Related]

  • 5. Corneal thickness measurement in the management of primary open-angle glaucoma: a report by the American Academy of Ophthalmology.
    Dueker DK, Singh K, Lin SC, Fechtner RD, Minckler DS, Samples JR, Schuman JS.
    Ophthalmology; 2007 Sep; 114(9):1779-87. PubMed ID: 17822980
    [Abstract] [Full Text] [Related]

  • 6. Optic disc hemorrhages in glaucoma and ocular hypertension: implications and recommendations.
    Uhler TA, Piltz-Seymour J.
    Curr Opin Ophthalmol; 2008 Mar; 19(2):89-94. PubMed ID: 18301280
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Risk factors for glaucoma onset and progression.
    Coleman AL, Miglior S.
    Surv Ophthalmol; 2008 Nov; 53 Suppl1():S3-10. PubMed ID: 19038621
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature.
    Jones R, Rhee DJ.
    Curr Opin Ophthalmol; 2006 Apr; 17(2):163-7. PubMed ID: 16552251
    [Abstract] [Full Text] [Related]

  • 14. Lifetime visual disability in open-angle glaucoma and ocular hypertension.
    Forsman E, Kivelä T, Vesti E.
    J Glaucoma; 2007 May; 16(3):313-9. PubMed ID: 17438426
    [Abstract] [Full Text] [Related]

  • 15. [Ocular hypertension--follow up or treatment?].
    Stefan C, Dumitrica DM, Dragomir L, Cristea I, Sapundgieva A.
    Oftalmologia; 2009 May; 53(2):23-5. PubMed ID: 19697835
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pathophysiology of intraocular pressure increase and glaucoma prevalence in thyroid eye disease: a mini-review.
    Haefliger IO, von Arx G, Pimentel AR.
    Klin Monbl Augenheilkd; 2010 Apr; 227(4):292-3. PubMed ID: 20408077
    [Abstract] [Full Text] [Related]

  • 18. Ocular hypertension and diabetes mellitus in the Beijing Eye Study.
    Xu L, Wang YX, Jonas JB, Wang YS, Wang S.
    J Glaucoma; 2009 Jan; 18(1):21-5. PubMed ID: 19142130
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.